Treatment of Hyperlipidemia With Alirocumab in a Liver Transplant Recipient With Poor Blood Lipid Control: Case Report
Transplantation Proceedings · 2024
DOI: 10.1016/j.transproceed.2024.05.015 ↗Kurz gefasst
Fallbericht in der Zeitschrift Transplantation Proceedings, 2024. Verfasst von Tie-Yan Fan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Hepatobiliary and Pancreatic Center of Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Hyperlipidemias, Liver Transplantation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
The use of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, such as alirocumab, to treat drug-resistant hypercholesterolemia is increasing; however, to date there have been no studies on the use of alirocumab to treat the hyperlipidemia that follows liver transplantation. Here we report a case of successful management of hyperlipidemia, albeit without total reversal of elevated serum triglycerides, with alirocumab monotherapy in a liver transplantation patient who was resistant to rosuvastatin and fenofibrate. In terms of safety, only transient palpitations following the first few alirocumab injections were recorded. This case illustrates that alirocumab can be a viable option for patients who experience poor lipid control after liver transplantation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Hepatobiliary and Pancreatic Center of Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.
- Department of Clinical Pharmacy of Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.
- Hepatobiliary and Pancreatic Center of Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China. Electronic address: ch61520@163.com.
Zitieren
APA
Fan, T. Y., Yan, Y., Lu, Q., Li, J., & Chen, H. (2024). Treatment of Hyperlipidemia With Alirocumab in a Liver Transplant Recipient With Poor Blood Lipid Control: Case Report. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2024.05.015
Vancouver
Fan TY, Yan Y, Lu Q, Li J, Chen H. Treatment of Hyperlipidemia With Alirocumab in a Liver Transplant Recipient With Poor Blood Lipid Control: Case Report. Transplantation Proceedings. 2024. doi:10.1016/j.transproceed.2024.05.015
BibTeX
@article{Fan2024,
author = {Fan, Tie-Yan and Yan, Yan and Lu, Qian and Li, Jun and Chen, Hong},
title = {Treatment of Hyperlipidemia With Alirocumab in a Liver Transplant Recipient With Poor Blood Lipid Control: Case Report},
journal = {Transplantation Proceedings},
year = {2024},
doi = {10.1016/j.transproceed.2024.05.015}
}
EUVIMED